SCHEMBL1317178

SCHEMBL1317178

Cc1ccccc1-c1ccc(C(=O)O)c(NC(=O)c2cc(N3CCCCC3)ccc2O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.52
GAA P10253 4/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ATM Q13315 1/20 0.44
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
SERPINE1 P05121 2/20 0.41
DHODH Q02127 1/20 0.41
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
BRPF1 P55201 1/20 0.41
KDM6B O15054 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1316176 0.91 MCL1 (0.54) MCL1GAAALDH1A1MAPTMAPK1
SCHEMBL12166086 0.89 MAPT (0.45) MCL1GAAALDH1A1MAPTNPC1
SCHEMBL1319800 0.89 ACMSD (0.52) MCL1ALDH1A1MAPTNPC1RAB9A
SCHEMBL1315669 0.88 ACLY (0.49) MCL1SERPINE1DHODHHDAC1HDAC2
SCHEMBL12117573 0.88 RXFP1 (0.50) GAAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL1316896 0.87 MAPT (0.42) MCL1GAAALDH1A1MAPTNPC1
Hydrochloric Acid SCHEMBL1317450 0.87 RXFP1 (0.49) GAAALDH1A1MAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL1316255 0.87 ACLY (0.48) MCL1SERPINE1DHODHHDAC1HDAC2
Hydrochloric Acid SCHEMBL1316485 0.87 ACLY (0.48) MCL1SERPINE1DHODHHDAC1HDAC2
SCHEMBL1317247 0.86 MCL1 (0.48) MCL1GAAALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed
WO-2010087430-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 MCL1 3649/4885GAA 877/4885ALDH1A1 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.